Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions

Journal of the American Society of Nephrology

Volumn 20, Issue 10, 2009, Pages 2119-2125

  Pozzi, Ambra ^a,b,c   Zent, Roy ^a,b,c   Chetyrkin, Sergei ^a   Borza, Corina ^a   Bulus, Nada ^a   Chuang, Peale ^a   Chen, Dong ^a   Hudson, Billy ^a,b   Voziyan, Paul ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; COLLAGEN TYPE 4; GLUCOSE; LYSINE; METHYLGLYOXAL;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CHEMICAL MODIFICATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULUS; GLYCATION; HYPERGLYCEMIA; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; CELL MOTION; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE IV; DIABETIC NEPHROPATHIES; GLUCOSE; MESANGIAL CELLS; MICE; PYRUVALDEHYDE;

EID: 70349909975     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2008080900     Document Type: Article

References (30)

1. Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes 54: 1615-1625, 2005 (Pubitemid 40770750)
2. Glomb MA, Monnier VM: Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270: 10,017-10,026, 1995
3. Ahmed MU, Thorpe SR, Baynes JW: Identification of N epsilon- carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261: 4889-4894, 1986
4. Voziyan PA, Khalifah RG, Thibaudeau C, Yildiz A, Jacob J, Serianni AS, Hudson BG: Modification of proteins in vitro by physiological levels of glucose: Pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end products through binding of redox metal ions. J Biol Chem 278: 46,616-46,624, 2003 (Pubitemid 37452237)
5. Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K: Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: Specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun 256: 89-93, 1999 (Pubitemid 29298922)
6. Lo TW, Westwood ME, McLellan AC, Selwood T, Thornalley PJ: Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alphaacetyllysine, and bovine serum albumin. J Biol Chem 269: 32,299-32,305, 1994
7. Thornalley PJ, Battah S, Ahmed N, Karachalias N, Agalou S, Babaei-Jadidi R, Dawnay A: Quantitative screening of advanced glycation end products in cellular and extracellular proteins by tandem mass spectrometry. Biochem J 375: 581-592, 2003 (Pubitemid 37433506)
8. Setty S, Anderson SS, Wayner EA, Kim Y, Clegg DO, Tsilibary EC: Glucose-induced alteration of integrin expression and function in cultured human mesangial cells. Cell Adhes Commun 3: 187-200, 1995
9. Haneda M, Koya D, Isono M, Kikkawa R: Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol 14: 1374-1382, 2003 (Pubitemid 36514677)
10. Brizzi MF, Dentelli P, Rosso A, Calvi C, Gambino R, Cassader M, Salvidio G, Deferrari G, Camussi G, Pegoraro L, Pagano G, Cavallo- Perin P: RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: A possible role in the development and progression of diabetic nephropathy. FASEB J 18: 1249-1251, 2004 (Pubitemid 39561566)
11. Crowley ST, Brownlee M, Edelstein D, Satriano JA, Mori T, Singhal PC, Schlondorff DO: Effects of nonenzymatic glycosylation of mesangial matrix on proliferation of mesangial cells. Diabetes 40: 540-547, 1991
12. Anderson SS, Kim Y, Tsilibary EC: Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation. Kidney Int 46: 1359-1367, 1994 (Pubitemid 24330714)
13. Skolnik EY, Yang Z, Makita Z, Radoff S, Kirstein M, Vlassara H: Human and rat mesangial cell receptors for glucose-modified proteins: Potential role in kidney tissue remodeling and diabetic nephropathy. J Exp Med 174: 931-939, 1991
14. Nagaraj RH, Sarkar P, Mally A, Biemel KM, Lederer MO, Padayatti PS: Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: Characterization of a major product from the reaction of pyridoxamine and methylglyoxal. Arch Biochem Biophys 402: 110-119, 2002 (Pubitemid 34848300)
15. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factorbeta. J Clin Invest 93: 536-542, 1994 (Pubitemid 24072793)
16. Mott JD, Khalifah RG, Nagase H, Shield CF III, Hudson JK, Hudson BG: Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int 52: 1302-1312, 1997 (Pubitemid 27496059)
17. Monnier VM, Mustata GT, Biemel KL, Reihl O, Lederer MO, Zhenyu D, Sell DR: Crosslinking of the extracellular matrix by the Maillard reaction in aging and diabetes: An update on "a puzzle nearing resolution". Ann N Y Acad Sci 1043: 533-544, 2005
18. Pedchenko VK, Chetyrkin SV, Chuang P, Ham AJ, Saleem MA, Mathieson PW, Hudson BG, Voziyan PA: Mechanism of perturbation of integrin- mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy. Diabetes 54: 2952-2960, 2005 (Pubitemid 41401092)
19. Zent R, Yan X, Su Y, Hudson BG, Borza DB, Moeckel GW, Qi Z, Sado Y, Breyer MD, Voziyan P, Pozzi A: Glomerular injury is exacerbated in diabetic integrin alpha1-null mice. Kidney Int 70: 460-470, 2006 (Pubitemid 44141572)
20. Pugliese F, Mene P, Cinotti GA: Glomerular polyanion and control of cell function. Am J Nephrol 10[Suppl 1]: 14-18, 1990
21. Pugliese G, Pricci F, Romeo G, Pugliese F, Mene P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U: Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes 46: 1881-1887, 1997
22. Liu BF, Miyata S, Hirota Y, Higo S, Miyazaki H, Fukunaga M, Hamada Y, Ueyama S, Muramoto O, Uriuhara A, Kasuga M: Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney Int 63: 947-957, 2003 (Pubitemid 36315572)
23. Yamagishi S, Inagaki Y, Okamoto T, Amano S, Koga K, Takeuchi M, Makita Z: Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells. J Biol Chem 277: 20,309 -20,315, 2002
24. Tuttle KR, Johnson EC, Cooney SK, Anderberg RJ, Johnson EK, Clifton GD, Meek RL: Amino acids injure mesangial cells by advanced glycation end products, oxidative stress, and protein kinase C. Kidney Int 67: 953-968, 2005
25. Wolf G, Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56: 393-405, 1999 (Pubitemid 29353136)
26. Ziyadeh FN, Wolf G: Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 4: 39-45, 2008
27. Steinitz M, Baraz L: A rapid method for estimating the binding of ligands to ELISA microwells. J Immunol Methods 238: 143-150, 2000 (Pubitemid 30175994)
28. Voziyan PA, Metz TO, Baynes JW, Hudson BG: A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem 277: 3397-3403, 2002
29. Kilhovd BK, Giardino I, Torjesen PA, Birkeland KI, Berg TJ, Thornalley PJ, Brownlee M, Hanssen KF: Increased serum levels of the specific AGE-compound methylglyoxal- derived hydroimidazolone in patients with type 2 diabetes. Metabolism 52: 163-167, 2003 (Pubitemid 36388837)
30. Chetyrkin SV, Zhang W, Hudson BG, Serianni AS, Voziyan PA: Pyridoxamine protects proteins from functional damage by 3-deoxyglucosone: Mechanism of action of pyridoxamine. Biochemistry 47: 997-1006, 2008